The study of Dou et al. indicated that the high USP32 expression was significantly related to a high T stage and poor prognosis in gastric cancer, and USP32 could stabilize SMAD2 protein level to promote cell growth, motility, and chemoresistance to cisplatin [41]. This evidence concerns the gene SMAD2 and gastric cancer.